These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8165633

  • 1. Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III.
    Baruch D, Ajzenberg N, Denis C, Legendre P, Lormeau JC, Meyer D.
    Thromb Haemost; 1994 Jan; 71(1):141-6. PubMed ID: 8165633
    [Abstract] [Full Text] [Related]

  • 2. Heparin binding assay of von Willebrand factor (vWF) in plasma milieu--evidence of the importance of the multimerization degree of vWF.
    de Romeuf C, Mazurier C.
    Thromb Haemost; 1993 May 03; 69(5):436-40. PubMed ID: 8322266
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
    Lormeau JC, Herault JP, Herbert JM.
    Thromb Haemost; 1996 Jul 03; 76(1):5-8. PubMed ID: 8819242
    [Abstract] [Full Text] [Related]

  • 6. Interaction of antithrombin III with surface-immobilized albumin-heparin conjugates.
    van Delden CJ, Engbers GH, Feijen J.
    J Biomed Mater Res; 1995 Nov 03; 29(11):1317-29. PubMed ID: 8582900
    [Abstract] [Full Text] [Related]

  • 7. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM, Goy C, Budek I, Seitz R.
    Semin Thromb Hemost; 2002 Apr 03; 28(2):139-48. PubMed ID: 11992237
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J.
    J Clin Invest; 1993 Jan 03; 91(1):273-82. PubMed ID: 8423224
    [Abstract] [Full Text] [Related]

  • 11. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST, Frances-Chmura AM, Swanson R, Björk I, Zettlmeissl G.
    Arch Biochem Biophys; 1997 May 15; 341(2):212-21. PubMed ID: 9169007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers.
    Abzalimov RR, Dubin PL, Kaltashov IA.
    Anal Chem; 2007 Aug 15; 79(16):6055-63. PubMed ID: 17658885
    [Abstract] [Full Text] [Related]

  • 20. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW.
    Thromb Haemost; 1980 Feb 29; 42(5):1434-45. PubMed ID: 7368150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.